| Trial ID: | L4511 |
| Source ID: | NCT00676741
|
| Associated Drug: |
Insulin Aspart
|
| Title: |
Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin
|
| Acronym: |
COMMIT
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: insulin aspart|DRUG: biphasic insulin aspart 30|DRUG: insulin detemir
|
| Outcome Measures: |
Primary: Metabolic control measured as HbA1c, for the duration of the study | Secondary: Percentage of subjects achieving HbA1c below 7.0% and below or equal 6.5%, after 12 weeks and 24 weeks|Change in FPG (glucose variability), after 12 weeks and 24 weeks|Change in PPG (postprandial control), after 12 weeks and 24 weeks|Change in insulin dose and number of injections, after 12 weeks and 24 weeks|Change in oral antidiabetic drug therapy, after 12 weeks and 24 weeks|Change in body weight, after 12 weeks and 24 weeks|Change in number of hypoglycaemic events during 4 weeks proceeding routine visits, after 12 weeks and 24 weeks|Number of adverse drug reactions (ADR), after 12 weeks and 24 weeks
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
3809
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2008-02
|
| Completion Date: |
2010-05
|
| Results First Posted: |
|
| Last Update Posted: |
2016-10-31
|
| Locations: |
Novo Nordisk Investigational Site, Bratislava, 811 05, Slovakia
|
| URL: |
https://clinicaltrials.gov/show/NCT00676741
|
